Neurorehabilitation News

Conscious sedation was not superior to general anesthesia for functional recovery in patients undergoing endovascular treatment following acute posterior circulation stroke, researchers reported in JAMA Neurology.

Revitalist Lifestyle and Wellness and Wake Network Inc. announced a joint venture to offer ketamine infusions in the U.S. and psilocybin clinical retreats internationally with a special focus on military veterans’ need for access.

The FDA has accepted a new drug application for aripiprazole, a 2-month, ready-to-use, long-acting injectable for the treatment of schizophrenia in adults and maintenance monotherapy treatment of bipolar I disorder in adults.

The FDA has granted breakthrough device designation to Magnus Medical for its neuromodulation treatment of major depressive disorder in adults who failed to achieve improvement from previously prescribed antidepressants.

LAS VEGAS — Lesser-known cannabinoids are showing potential for treating neurological disease, inflammation, pain, cancer and infection, according to dermatologist Jeanette Jacknin, MD.

Cerveau Technologies Inc. announced a partnership with Alnylam Pharmaceuticals, which will use Cerveau’s investigational imaging agent in positron emission tomography scans to evaluate neurofibrillary tangles in the brain.

Canadian-based Neurolytixs Inc. announced it has secured a United States patent for technology that can identify mild traumatic brain injuries more accurately and rapidly, particularly in young athletes with concussions.

Introducing electroconvulsive therapy earlier in a treatment course for major depressive disorder or bipolar disorder may lead to improvements in clinical outcomes, according to a study published in the Journal of Clinical Psychiatry.

Biomarkers collected on the day of traumatic brain injury had significant prognostic value for death and unfavorable outcome but not for incomplete recovery at 6 months, according to a study published in The Lancet Neurology.

Blinkcns Inc. and the Zucker Institute for Innovation Commercialization at the Medical University of South Carolina have announced a licensing agreement to advance blink reflex technology and software EyeStat.